Kolkata, West Bengal -- (SBWIRE) -- 09/13/2013 -- Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on Johnson & Johnson (NYSE:JNJ), Gilead Sciences, Inc.(NASDAQ:GILD), Zynga Inc(NASDAQ:ZNGA).
Johnson & Johnson (NYSE:JNJ) shares decreased 0.25% to $89.01. The company on Sept. 11 is voluntarily recalling one lot of schizophrenia drug Risperdal Consta after discovering mold during a routine testing process, a company spokeswoman said, the latest in a string of recalls over the past two years. Risperdal Consta is manufactured by Janssen Pharmaceuticals, a unit of Johnson & Johnson. The company is recalling the drug from wholesalers, distributors, pharmacies and healthcare providers.
Should Investors Buy JNJ After Yesterday’s Jump? Find Out Here
Gilead Sciences, Inc.(NASDAQ:GILD) shares gained 0.41% to $63.19. The company on Sept. 12 announced 48-week results from a Phase 2 study (Study 102) evaluating an investigational once-daily single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection. At 48 weeks, a regimen of elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/TAF 10 mg was found to be similar to Stribild® (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) based on the percentage of patients with HIV RNA levels less than 50 copies/mL, and was associated with more favorable renal and bone safety markers. These findings were presented today in a latebreaker session (Abstract #H-1464d) at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2013) taking place in Denver.
How Should Investors Trade GILD After The Recent Volatility? Get Free Trend Analysis Here
Zynga Inc(NASDAQ:ZNGA) shares gained 0.67% to $3.02. Wible initiated coverage on Zynga on August 20 with a sell rating, citing “concerns around the next generation game cycle, casual user fatigue, competition, and marketing constraints/pressure.”
Additionally, Zynga on August 30 has announced the biggest ever game play update to its flagship title, Farmville 2. The so called “Appaloosa River” expansion will be rolled out to players of the social game for free in September. Following the Zynga Inc (NASDAQ:ZNGA) “freemium” strategy, the expansion will be available to players early if they’re willing to spend on it.
Is ZNGA A Good Buy After The Recent Price Movement? Find Out Here
Specialpennystockalert.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. Specialpennystockalert.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at Specialpennystockalert.com.
The assembled information disseminated by Specialpennystockalert.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Specialpennystockalert.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)